Related Experiment Video

Updated: May 21, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

The role of PARP1 in the DNA damage response and its application in tumor therapy

Zhifeng Wang1, Fengli Wang, Tieshan Tang

  • 1Laboratory of Disease Genomics and Individual Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100029, China.

Frontiers of Medicine
|June 5, 2012
PubMed

Insights

Poly(ADP-ribose) polymerase 1 (PARP1) is crucial for DNA repair and a cancer therapy target. This review explores PARP1

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Poly(ADP-ribose) polymerase 1 (PARP1) is vital in DNA damage response pathways.
  • PARP inhibitors show promise as anti-cancer agents by targeting PARP1.
  • The precise mechanisms of PARP inhibitors in cancer therapy are complex and still emerging.

Purpose of the Study:

  • To review recent advancements in understanding PARP1's role in DNA damage response.
  • To discuss the application and complexities of PARP inhibitors in cancer treatment.
  • To explore mechanisms of resistance to PARP inhibitors in BRCA-deficient tumors.

Main Methods:

  • Literature review of recent research on PARP1 and PARP inhibitors.
  • Analysis of studies on DNA damage response pathways involving PARP1.
  • Examination of clinical and preclinical data on PARP inhibitor efficacy and resistance.

Main Results:

  • PARP1 plays a central role in multiple DNA damage repair pathways.
  • PARP inhibitors are effective in certain cancers but resistance mechanisms are developing.
  • Understanding these mechanisms is key to optimizing treatment strategies.

Conclusions:

  • PARP1 is a significant target for cancer therapy, with inhibitors showing therapeutic potential.
  • Further research is needed to elucidate complex mechanisms and overcome resistance.
  • Advances will guide patient selection and combination therapy development for improved outcomes.

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...